LX Financial Statements & Analysis
Complete financial statements for LX including income statement, balance sheet, and cash flow statement. Analyze LX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-9.9% ↓
Net Income
48.2% ↑
Gross Margin
104.2% ↑
Operating Margin
10.0% ↑
Balance Sheet
Current Ratio
120.1% ↑
Debt to Equity
-18.2% ↑
Asset Turnover
-13.6% ↓
Cash Flow
Operating Cash Flow
234.2% ↑
Net Cash Flow
86.8% ↑
Free Cash Flow
290.9% ↑
Cash Flow to Debt
267.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 14.20B | 12.79B | 9.9% | |
| Gross Profit | 5.03B | 9.24B | 83.9% | |
| Operating Income | 2.29B | 2.26B | 1.0% | |
| Net Income | 1.10B | 1.63B | 48.2% | |
| EPS | 6.64 | 9.64 | 45.2% | |
| EBITDA | 1.51B | 2.37B | 56.6% | |
| Gross Margin | 35.39% | 72.25% | 104.2% | |
| Operating Margin | 16.10% | 17.70% | 10.0% | |
| Net Income Margin | 7.75% | 12.75% | 64.6% | |
| R&D Expenses | 578.24M | 595.32M | 3.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 12.79B | 14.20B | 13.06B | — | — |
| Gross Profit | 9.24B | 5.03B | 4.51B | — | — |
| Operating Income | 2.26B | 2.29B | 1.88B | — | — |
| Net Income | 1.63B | 1.10B | 1.07B | — | — |
| EPS | 9.64 | 6.64 | 6.48 | — | — |
| EBITDA | 2.37B | 1.51B | 1.52B | — | — |
| Gross Margin | 72.25% | 35.39% | 34.56% | — | — |
| Operating Margin | 17.70% | 16.10% | 14.39% | — | — |
| Net Income Margin | 12.75% | 7.75% | 8.16% | — | — |
| R&D Expenses | 595.32M | 578.24M | 513.28M | — | — |
Financial Metrics
Want to dive deeper into LX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics